CEVA Insiders Buy as Analysts Eye Q2 Profitability Turnaround

Saturday, Aug 8, 2026 2:04 am ET2min read
CEVA--
Aime RobotAime Summary

- CevaCEVA-- projects Q2 2026 revenue of $28.69M and $0.07 EPS, reversing Q1's $4.46M net loss.

- Analysts set $36–$55 price targets, reflecting optimism about recovery despite valuation uncertainty.

- Executives bought $173K+ in shares, while institutional holdings show mixed strategies with major position changes.

- Strong top-line growth (11.46% YoY) contrasts with bottom-line volatility, highlighting operational improvements.

Forward-Looking Analysis

Analysts project Ceva’s second-quarter 2026 revenue to reach $28,686,480, reflecting a positive trajectory from the prior year’s figures. Earnings per share (EPS) estimates stand at $0.07, indicating a return to profitability after the previous quarter’s loss. Refinitiv data confirms the expectation of earnings of 7 cents per share. Institutional sentiment remains divided but generally optimistic, with a median price target of $45 set by six analysts over the last six months. Needham’s Charles Shi maintains a bullish stance with a $55 target, while JP Morgan’s Samik Chatterjee offers a more conservative $36 target. Other notable targets include UBS at $48, Oppenheimer at $42, and TD Cowen and Rosenblatt both at $45. These figures suggest a consensus view that the company is stabilizing its financial performance, though price targets vary significantly based on individual analyst risk assessments. The projected EPS of $0.07 contrasts sharply with the previous quarter's negative earnings, signaling expected operational improvements. No significant upgrades or downgrades were noted in the provided summaries, but the range of price targets highlights differing views on the company's near-term growth potential amidst broader market conditions.

Historical Performance Review

In Q1 2026, CevaCEVA-- reported revenue of $27.02 million, marking an 11.46% year-over-year increase. However, the company recorded a net income loss of $-4.46 million, resulting in an EPS of $-0.16. Despite the net loss, gross profit remained robust at $23.30 million, indicating strong top-line growth and effective cost management in the cost of goods sold, even as operating expenses or other factors contributed to the bottom-line deficit.

Additional News

Insider activity for Ceva has been exclusively positive over the past six months, with three executives making purchases. CEO Amir Panush bought 5,100 shares for approximately $100,470, CFO Yaniv Arieli purchased 2,500 shares for $48,350, and Jaclyn Liu acquired 1,310 shares for $25,086. This buying trend suggests internal confidence in the company's future. On the institutional side, hedge fund activity was mixed. State Street Corp increased its position by 34.6% (430,418 shares) in Q2 2026, and Two Sigma Investments added 314.8% (229,820 shares) in Q1 2026. Conversely, Handelsbanken Fonder AB completely exited its position, removing 684,465 shares, while Millennium Management and Rice Hall James reduced holdings significantly. These moves indicate divergent institutional strategies, with some funds doubling down on the stock while others divest. The company is also exploring AI applications in logistics through "The CEVA Pod," though this appears distinct from the semiconductor entity's core operations.

Summary & Outlook

Ceva demonstrates improving revenue growth, up 11.46% in Q1, yet remains unprofitable with a net loss in that quarter. The Q2 2026 consensus anticipates a turnaround to a positive EPS of $0.07 and higher revenue, suggesting a path to profitability. Insider buying provides a bullish signal, while mixed institutional activity reflects caution. The broad range of analyst price targets ($36–$55) indicates uncertainty in valuation but general optimism about recovery. Overall, the financial health shows top-line strength with bottom-line volatility. The primary catalyst is the expected return to earnings. The outlook is cautiously bullish, contingent on sustaining revenue growth and achieving consistent profitability in upcoming quarters.

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet